- Cree (CREE) and Rubicon Technology (RBCN) to buy from neutral at Merriman.
- Children's Place (PLCE) to outperform from market perform at BMO Capital.
- Lockheed Martin (LMT) to neutral from underperform at BofA/Merrill.
- Copano Energy (CPNO) to outperform from market perform at Morgan Keegan.
- Motorola Mobility (MMI) to neutral from reduce at Nomura.
- Parker-Hannifin (PH) to buy from hold at KeyBanc.
- Akamai (AKAM), ShoreTel (SHOR), AMB Property (AMB) and ProLogis (PLD) to buy from hold at Stifel Nicolaus.
- LifePoint Hospitals (LPNT) to underperform from market perform at Leerink.
- American Eagle (AEO) to market perform from outperform at BMO Capital.
- BMC Software (BMC) to hold from buy at Stifel Nicolaus.
- Guess (GES) to neutral from buy at Buckingham.
- Lawson Software (LWSN) to neutral from buy at Longbow.
- China Integrated Energy (CBEH) to neutral from buy at Roth Capital.
- Apple (AAPL), Hewlett-Packard (HPQ) and EMC (EMC) initiated with outperform ratings, as well as IBM (IBM) with a neutral and Dell (DELL) and Lexmark (LXK) at underperform, at Credit Suisse.
- MedQuist (MEDH) and Endocyte (ECYT) with an outperform at RBC Capital.
- Life Technologies (LIFE), Sequenom (SQNM), Complete Genomics (GNOM) and Cepheid (CPHD) with an outperform, as well as Affymetrix (AFFX) and Myriad Genetics (MYGN) with a perform, at Oppenheimer.